NCT05880160View on ClinicalTrials.gov

Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 14, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
CardiotoxicityHER2-positive Breast CancerHeart FailureCancer, Therapy-Related
Interventions
OTHER

Phased withdrawal of heart failure medications

As per arm/group description

Trial Locations (2)

EC1A 7BE

RECRUITING

St Bartholemew's Hospital, London

NW1 2BU

RECRUITING

University College London Hospital, London

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

collaborator

Barts & The London NHS Trust

OTHER

collaborator

University College London Hospitals

OTHER

lead

University College, London

OTHER